drugset / Trial / NCT00901979

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

NCT00901979

Phase 2 Completed 693 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will assess the effect of LCQ when added to metformin.

Timeline

Start
2009-04
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pradigastat Small molecule
Comparator Sitagliptin Small molecule
Background Metformin Small molecule